TL;DR
WUSAPP is a part of the Washington University Scalable Mouse Assay Center (WU-SMAC) focusing on systematic investigation on neurodevelopmental and psychiatric disorders (NPDs)-associated mutation effect on baseline, innate auditory-driven behavior.
We focus on the development of an open, scalable, and high-throughput assay completed with analysis tools to assess auditory-driven behavior in mice.
WUSAPP - the Abstract
Washington University Scalable Auditory Place Preference Assay
Increased research on neurodevelopmental and psychiatric disorders (NPDs) highlights the need for large-scale behavioral phenotyping across genetic models. One major gap is the lack of systematic investigation on NPD-associated mutation effect on baseline, innate auditory-driven behavior. The Washington University Scalable Mouse Assay Center (WU-SMAC) formed to collect behavioral and genetic data across 100 NPD-associated genes over five years. We joined the consortium, addressing the auditory behavior gap by developing a non-conditioned auditory place preference assay (APP) to measure innate auditory-driven behavior in adolescent mice.
To assess sensitivity to communication-relevant spectrotemporal structure, we paired an adult ultrasonic vocalization (social call, SC) with a temporally inverted version of the same call (temporally inverted SC, TI-SC). To assess responses to a salient nonsocial auditory stimulus, we paired a novel SC with a broadband whitenoise burst (broadband nonsocial stimulus, BBN), comparing social-call responses against an acoustically salient but non-social control. Mice aged 6-8 weeks are presented with the alternating SC/TI-SC and SC/BBN stimulus pairs across two trials in a dark two-compartment rectangular arena with a connecting central corridor. Baseline activity is recorded prior to each trial. The assay captures natural, untrained responses to auditory stimuli, measuring multiple behavioral outputs, including approach/avoidance, freezing, and startle, across models with diverse activity levels. However, scaling this approach requires high-throughput acquisition and analysis, as manual scoring is slow, subjective, and low resolution.
To support high-throughput implementation, we designed an open-hardware arena and stimulus-presentation system. To eliminate reliance on manual scoring, we developed an open-source analysis pipeline integrating pose-estimation tools such as SLEAP and DeepLabCut with behavior-segmentation tools such as Keypoint-MoSeq and SimBA.
Validated across multiple NPD-associated mouse models, including TSC2, SCN1A, FBN1, MECP2, and SHANK3, we are using APP to generate quantitative auditory-behavioral fingerprints which will enable cross-model ranking of phenotypic similarity, identification of shared and divergent auditory-behavioral signatures, and cross-validation with downstream WU-SMAC behavioral assays. With 50 cohorts planned over five years, APP provides a standardized and scalable platform for large-scale phenotyping of innate auditory behavior across NPD-associated genetic models.
About WU-SMAC
The Washington University Scalable Mouse Assay Center (WU-SMAC) aims to better understand how genetic mutations linked to conditions like autism, schizophrenia, and intellectual disability affect the brain and behavior. By studying over 100 different mouse models, we will explore how these mutations impact brain function using advanced techniques like behavior tracking, anatomical mapping, and gene analysis. Our goal is to uncover how these genes change the brain and contribute to neurodevelopmental and psychiatric conditions, with the hope of advancing treatments in the future. We are an assay and data generation center (ADGC) for the SSPsyGene Consortium.
Official Website: https://sites.wustl.edu/wusmac/
Our Mission
In the past decade, significant progress has been made in identifying genetic variants associated with neurodevelopmental and psychiatric conditions like autism, schizophrenia, and intellectual disability. However, understanding how these genes affect brain function and contribute to disease remains a challenge due to the diverse experimental approaches used. To address this, we have assembled the Washington University Scalable Mouse Assay Center (WU-SMAC), an Assay and Data Generation Center (ADGC) for the SSPsyGene consortium. We will comprehensively investigate the impact of prioritized mutations known to cause neurodevelopmental and psychiatric conditions using over 100 mouse lines. Through a combination of behavioral analysis, anatomical mapping, and molecular assessments, our project seeks to uncover the molecular and spatial changes in the brain caused by these mutations and their subsequent effects on behavior. We will deeply assess the phenotype of each mutant using high-content, machine-learning driven behavioral analysis, automated home-cage monitoring of learning behavior and cognitive flexibility, and careful single nucleus & spatial transcriptomics. We will coordinate data serving and distribution with the other ADGCs and Data Resource and Administrative Coordination Center, and provide a unique mouse neuropsychiatric disease brain bank for the entire consortium to enable the replication of findings from other ADGC’s systems within the complex milieu of a fully developed mammalian brain.
The SSPsyGene Consortium
The SSPsyGene Consortium aims to create a comprehensive catalog of genotypes and phenotypes for genes associated with neurodevelopmental and psychiatric disorders (NPDs), addressing the current research gap where most studies focus on a small subset of genes, limiting our understanding of gene function and disease mechanisms. By using scalable, systematic assays across various biological levels—from molecular to organismal—the consortium will provide detailed data on the neurobiological functions of NPD risk genes, which will be integrated and shared for future research into conditions like autism and schizophrenia. The initiative involves Assay and Data Generation Centers (ADGCs) to develop and implement these assays, and a Data Resource and Administrative Coordinating Center (DRACC) to coordinate efforts, manage data, and ensure its accessibility. The initial phase will focus on 100-250 protein-coding genes, with the goal of understanding their basic functions and, over time, exploring the effects of genetic variations linked to NPDs.
Commitment to FAIR Data and Resource Sharing
As a data generation center, we are committed to keeping our data Findable, Accessible, Interoperable, and Reusable (FAIR). All metadata and data will be uniquely identifiable and shared to the appropriate repositories upon publication or at the completion of the project. Additionally, any unique code generated by the project will be deposited in an open source repository as appropriate.
We also plan to establish a NPD Mouse Brain Bank where we will save tissues from each mouse line generated to share upon request with other WashU and SSPsyGene researchers. Along with tissues, we will also communicate information regarding live mice as they become available. Our goal is to keep all resources and technologies developed as part of this project widely available and accessible to the greater research community.